Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies.

Autor: Smyth D; Department of Neurology, Lewisham and Greenwich NHS Foundation Trust, London, UK; UCL Queen Square Institute of Neurology, London, UK., Kyaw KM; Department of Neurology, Kings College Hospital NHS Foundation Trust, London, UK., Legister A; Department of Geriatric Medicine, Stroke and Palliative Care, Lewisham and Greenwich NHS Foundation Trust, London, UK., MacFarlane G; Department of Geriatric Medicine, Stroke and Palliative Care, Lewisham and Greenwich NHS Foundation Trust, London, UK., Sankar UU; Department of Geriatric Medicine, Stroke and Palliative Care, Lewisham and Greenwich NHS Foundation Trust, London, UK., Patel M; Department of Geriatric Medicine, Stroke and Palliative Care, Lewisham and Greenwich NHS Foundation Trust, London, UK., Clough C; Department of Neurology, Kings College Hospital NHS Foundation Trust, London, UK., Kulendran A; Department of Geriatric Medicine, Stroke and Palliative Care, Lewisham and Greenwich NHS Foundation Trust, London, UK., Mulroy E; Department of Neurology, Lewisham and Greenwich NHS Foundation Trust, London, UK; UCL Queen Square Institute of Neurology, London, UK. Electronic address: eoin.mulroy@nhs.net.

Publikováno v: Journal of the neurological sciences [J Neurol Sci] 2021 Nov 15; Vol. 430, pp. 119982. Date of Electronic Publication: 2021 Sep 15.